From cellular senescence to Alzheimer's disease: The role of telomere shortening

Ageing Research Reviews

Volumn 22, Issue , 2015, Pages 1-8

  Boccardi, Virginia ^a   Pelini, Luca ^a   Ercolani, Sara ^a   Ruggiero, Carmelinda ^a   Mecocci, Patrizia ^a  

^a UNIVERSITY OF PERUGIA   (Italy)

Author keywords

Aging; Alzheimer's disease; Senescence; Telomerase; Telomeres

Indexed keywords

ALPHA INTERFERON; AMYLOID BETA PROTEIN; BIOLOGICAL MARKER; CYCLINE; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 1BETA; INTERLEUKIN 6; PRESENILIN 1; PROTEIN P53; STROMELYSIN; TAU PROTEIN; TELOMERASE; TUMOR NECROSIS FACTOR ALPHA;

ALZHEIMER DISEASE; AMNESIA; BRAIN CELL; BRAIN REGION; CELL AGING; CELL FUNCTION; COGNITION; COGNITIVE DEFECT; DISEASE ASSOCIATION; DNA DAMAGE; ENERGY METABOLISM; ENZYME ACTIVITY; HEALTH CARE SYSTEM; HUMAN; NEURAL STEM CELL; NEUROFIBRILLARY TANGLE; NEUROTOXICITY; NONHUMAN; OXIDATIVE STRESS; PATHOGENESIS; PHENOTYPE; REVIEW; RISK FACTOR; SENILE PLAQUE; SHORT TERM MEMORY; TELOMERE HOMEOSTASIS; TELOMERE SHORTENING; AGING; ANIMAL; METABOLISM; PHYSIOLOGY;

AGING; ALZHEIMER DISEASE; ANIMALS; CELL AGING; HUMANS; OXIDATIVE STRESS; RISK FACTORS; TELOMERE SHORTENING;

EID: 84928328478     PISSN: 15681637     EISSN: 18729649     Source Type: Journal    
DOI: 10.1016/j.arr.2015.04.003     Document Type: Review

References (109)

1. Aubert G., Lansdorp P.M. Telomeres and aging. Physiol. Rev. 2008, 88:557-579.
2. Bachstetter A.D., Xing B., de Almeida L., Dimayuga E.R., Watterson D.M., Van Eldik L.J. Microglial p38alpha MAPK is a key regulator of proinflammatory cytokine upregulation induced by toll-like receptor (TLR) ligands or beta-amyloid (Abeta). J. Neuroinflammation 2011, 8:79.
3. Baird D.M., Kipling D. The extent and significance of telomere loss with age. Ann. N. Y. Acad. Sci. 2004, 1019:265-268.
4. Benarroch E.E. Neuron-astrocyte interactions: partnership for normal function and disease in the central nervous system. Mayo Clin. Proc. 2005, 80:1326-1338.
5. Bhat R., Crowe E.P., Bitto A., Moh M., Katsetos C.D., Garcia F.U., Johnson F.B., Trojanowski J.Q., Sell C., Torres C. Astrocyte senescence as a component of Alzheimer's disease. PLoS One 2012, 7:e45069.
6. Bitto A., Sell C., Crowe E., Lorenzini A., Malaguti M., Hrelia S., Torres C. Stressinduced senescence in human and rodent astrocytes. Exp. Cell Res. 2010, 316:2961-2968.
7. Blackburn E.H. Telomere states and cell fates. Nature 2000, 408(6808):53-56.
8. Blasco M.A. Telomeres and human disease: ageing, cancer and beyond. Nat. Rev. Genet. 2005, 6:611-622.
9. Boccardi V., Paolisso G. Malleability of short telomeres by telomerase activators: a mini-review. J. Aging Sci. 2013, 1:108.
10. Boccardi V., Herbig U. Telomerase gene therapy: a novel approach to combat aging. EMBO Mol. Med. 2012, 4(8):685-687.
11. Boccardi V., Paolisso G. Telomerase activation: a potential key modulator for human healthspan and longevity. Ageing Res. Rev. 2014, 15:1-5.
12. Bodnar A.G., Ouellette M., Frolkis M., Holt S.E., Chiu C.P., Morin G.B., Harley C.B., Shay J.W., Lichtsteiner S., Wright W.E. Extension of life-span by introduction of telomerase into normal human cells. Science 1998, 279(5349):349-352.
13. Bonda D.J., Bajić V.P., Spremo-Potparevic B., Casadesus G., Zhu X., Smith M.A., Lee H.G. Review: cell cycle aberrations and neurodegeneration. Neuropathol. Appl. Neurobiol. 2010, 36(2):157-163.
14. Brookmeyer R., Johnson E., Ziegler-Graham K., Arrighi H.M. Forecasting the global burden of Alzheimer's disease. Alzheimers Dement. 2007, 3:186-191.
15. Campisi J. Senescent cells, tumor suppression, and organismal aging: good citizens, bad neighbors. Cell 2005, 120:513-522.
16. Campisi J., d'Adda di Fagagna F. Cellular senescence: when bad things happen to good cells. Nat. Rev. Mol. Cell Biol. 2007, 8:729-740.
17. Casoli T., Balietti M., Giorgetti B., Solazzi M., Scarpino O., Fattoretti P. Platelets in Alzheimer's disease-associated cellular senescence and inflammation. Curr. Pharm. Des. 2013, 19(9):1727-1738.
18. Chen W., Kimura M., Kim S., Cao X., Srinivasan S.R., Berenson G.S.J.D., Kark A.A., Aviv A. Longitudinal A versus cross-sectional evaluations of leukocyte telomere length dynamics: age-dependent telomere shortening is the rule. J. Gerontol. Ser. A Biol. Sci. Med. Sci. 2011, 66:312-319.
19. Chinta S.J., Woods G., Rane A., Demaria M., Campisi J., Andersen J.K. Cellular senescence and the aging brain. Exp. Gerontol. 2014, pii: S0531-5565(14)00275-7 [Epub ahead of print].
20. Collado M., Blasco M.A., Serrano M. Cellular senescence in cancer and aging. Cell 2007, 130(2):223-233.
21. Coppe J.P., Desprez P.Y., Krtolica A., Campisi J. The senescence-associated secretory phenotype: the dark side of tumor suppression. Ann. Rev. Pathol. 2010, 5:99-118.
22. Coppe J.P., Patil C.K., Rodier F., Krtolica A., Beausejour C.M., Parrinello S., Hodgson J.G., Chin K., Desprez P.Y., Campisi J. A human-like senescence-associated secretory phenotype is conserved in mouse cells dependent on physiological oxygen. PLoS One 2010, 5:e9188.
23. de Jesus B.B., Vera E., Schneeberger K., Tejera A.M., Ayuso E., Bosch F., Blasco M.A. Telomerase gene therapy in adult and old mice delays aging and increases longevity without increasing cancer. EMBO Mol. Med. 2012, 4:1-14.
24. de Lange T. Protection of mammalian telomeres. Oncogene 2002, 21:532-540.
25. Demetrius L.A., Driver J. Alzheimer's as a metabolic disease. Biogerontology 2013, 14(6):641-649.
26. Diniz D.G., Foro C.A., Rego C.M., Gloria D.A., de Oliveira F.R., Paes J.M., de Sousa A.A., Tokuhashi T.P., Trindade L.S., Turiel M.C., Vasconcelos E.G., Torres J.B., Cunnigham C., Perry V.H., Vasconcelos P.F., Diniz C.W. Environmental impoverishment and aging alter object recognition, spatial learning, and dentate gyrus astrocytes. Eur. J. Neurosci. 2010, 32:509-519.
27. Eitan E., Hutchison E.R., Mattson M.P. Telomere shortening in neurological disorders: an abundance of unanswered questions. Trends Neurosci. 2014, 37(5):256-263.
28. Eitan E., Tichon A., Daniel G., Priel E. Telomerase expression in adult and old mouse Purkinje neurons. Rejuvenation Res. 2012, 15:206-209.
29. Eitan E., Tichon A., Gazit A., Gitler D., Slavin S., Priel E. Novel telomerase-increasing compound in mouse brain delays the onset of amyotrophic lateral sclerosis. EMBO Mol. Med. 2012, 4:313-329.
30. Fabricius K., Jacobsen J.S., Pakkenberg B. Effect of age on neocortical brain cells in 90+ year old human females - a cell counting study. Neurobiol. Aging 2013, 34:91-99.
31. Fernandez M., Gobartt A.L., Balana M. COOPERA Study Group. Behavioural symptoms in patients with Alzheimer's disease and their association with cognitive impairment. BMC Neurol. 2010, 10:87.
32. Ferrón S.R., Marqués-Torrejón M.A., Mira H., Flores I., Taylor K., Blasco M.A., Fariñas I. Telomere shortening in neural stem cells disrupts neuronal differentiation and neuritogenesis. J. Neurosci. 2009, 29:14394-14407.
33. Flanary B.E., Streit W.J. Effects of axotomy on telomere length, telomerase activity, and protein in activated microglia. J. Neurosci. Res. 2005, 82:160-171.
34. Flanary B.E., Sammons N.W., Nguyen C., Walker D., Streit W.J. Evidence that aging and amyloid promote microglial cell senescence. Rejuvenation Res. 2007, 10(1):61-74.
35. Flanary B.E., Streit W.J. Telomeres shorten with age in rat cerebellum and cortex in vivo. J. Anti Aging Med. 2003, 6:299-308.
36. Flanary B.E., Streit W.J. Progressive telomere shortening occurs in cultured rat microglia, but not astrocytes. Glia 2004, 45:75-88.
37. Franco S., Blasco M.A., Siedlak S.L., Harris P.L., Moreira P.I., Perry G., Smith M.A. Telomeres and telomerase in Alzheimer's disease: epiphenomena or a new focus for therapeutic strategy?. Alzheimers Dement. 2006, 2:164-168.
38. Fu W., Killen M., Culmsee C., Dhar S., Pandita T.K., Mattson M.P. The catalytic subunit of telomerase is expressed in developing brain neurons and serves a cell survival-promoting function. J. Mol. Neurosci. 2000, 14:3-15.
39. Fu W., Lee J., Guo Z., Mattson M.P. Seizures and tissue injury induce telomerase in hippocampal microglial cells. Exp. Neurol. 2002, 178:294-300.
40. Fumagalli M., Rossiello F., Mondello C., d'Adda di Fagagna F. Stable cellular senescence is associated with persistent DDR activation. PLoS One 2014, 9(10):e110969.
41. Fumagalli M., Rossiello F., Clerici M., Barozzi S., Cittaro D., Kaplunov J.M., Bucci G., Dobreva M., Matti V., Beausejour C.M., Herbig U., Longhese M.P., d'Adda di Fagagna F. Telomeric DNA damage is irreparable and causes persistent DNA-damage-response activation. Nat. Cell Biol. 2012, 14(4):355-365. Erratum in: Nat. Cell Biol., 2012, May; 14(5): 555.
42. Guan J.Z., Guan W.P., Maeda T., Makino N. The subtelomere of short telomeres is hypermethylated in Alzheimer's disease. Aging Dis. 2012, 3(2):164-170.
43. Guan J.Z., Guan W.P., Maeda T., Makino N. Analysis of telomere length and subtelomeric methylation of circulating leukocytes in women with Alzheimer's disease. Aging Clin. Exp. Res. 2013, 25:17-23.
44. Harley C.B., Futcher A.B., Greider C.W. Telomeres shorten during ageing of human fibroblasts. Nature 1990, 345:458-460.
45. Hayflick L. The cell biology of human aging. N. Engl. J. Med. 1976, 295(23):1302-1308.
46. Hebert L.E., Scherr P.A., Bienias J.L., Bennett D.A., Evans D.A. Alzheimer disease in the US population: prevalence estimates using the 2000 census. Arch. Neurol. 2003, 60:1119-1122.
47. Heneka M.T., Sastre M., Dumitrescu-Ozimek L., Dewachter I., Walter J., Klockgether T., Van Leuven F. Focal glial activation coincides with increased BACE1 activation and precedes amyloid plaque deposition in APP[V717I] transgenic mice. J. Neuroinflammation 2005, 2:22.
48. Herbig U., Ferreira M., Condel L., Carey D., Sedivy J.M. Cellular senescence in aging primates. Science 2006, 311:1257.
49. Herbig U., Sedivy J.M. Regulation of growth arrest in senescence: telomere damage is not the end of the story. Mech. Ageing Dev. 2006, 127:16-24.
50. Hewitt G., Jurk D., Marques F.D., Correia-Melo C., Hardy T., Gackowska A., Anderson R., Taschuk M., Mann J., Passos J.F. Telomeres are favoured targets of a persistent DNA damage response in ageing and stress-induced senescence. Nat. Commun. 2012, 28(3):708.
51. Hochstrasser T., Marksteiner J., Humpel C. Telomere length is age-dependent and reduced in monocytes of Alzheimer patients. Exp. Gerontol. 2012, 47(2):160-163.
52. Honig L.S., Schupf N., Lee J.H., Tang M.X., Mayeux R. Shorter telomeres are associated with mortality in those with APOE epsilon4 and dementia. Ann. Neurol. 2006, 60:181-187.
53. Jaskelioff M., Muller F.L., Paik J.H., Thomas E., Jiang S., Adams A.C., Sahin E., Kost-Alimova M., Protopopov A., Cadiñanos J., Horner J.W., Maratos-Flier E., Depinho R.A. Telomerase reactivation reverses tissue degeneration in aged telomerase-deficient mice. Nature 2011, 469:102-106.
54. Jenkins E.C., Velinov M.T., Ye L., Gu H., Li S., Jenkins E.C., Brooks S.S., Pang D., Devenny D.A., Zigman W.B., Schupf N., Silverman W.P. Telomere shortening in T lymphocytes of older individuals with Down syndrome and dementia. Neurobiol. Aging 2006, 27:941-945.
55. Jeyapalan J.C., Ferreira M., Sedivy J.M., Herbig U. Accumulation of senescent cells in mitotic tissue of aging primates. Mech. Ageing Dev. 2007, 128:36-44.
56. Jeyapalan J.C., Sedivy J.M. Cellular senescence and organismal aging. Mech. Ageing Dev. 2008, 129:467-474.
57. Jiang T., Cadenas E. Astrocytic metabolic and inflammatory changes as a function of age. Aging Cell 2014, 13(6):1059-1067.
58. Jurk D., Wang C., Miwa S., Maddick M., Korolchuk V., Tsolou A., Gonos E.S., Thrasivoulou C., Saffrey M.J., Cameron K., von Zglinicki T. Postmitotic neurons develop a p21-dependent senescence-like phenotype driven by a DNA damage response. Aging Cell 2012, 11:996-1004.
59. Klapper W., Shin T., Mattson M.P. Differential regulation of telomerase activity and TERT expression during brain development in mice. J. Neurosci. Res. 2001, 64:252-260.
60. Klement K., Goodarzi A.A. DNA double strand break responses and chromatin alterations within the aging cell. Exp. Cell Res. 2014, 329(1):42-52.
61. Lee J., Jo Y.S., Sung Y.H., Hwang I.K., Kim H., Kim S.Y., Yi S.S., Choi J.S., Sun W., Seong J.K., Lee H.W. Telomerase deficiency affects normal brain functions in mice. Neurochem. Res. 2010, 35:211-218.
62. Liu L., Rando T.A. Manifestations and mechanisms of stem cell aging. J. Cell Biol. 2011, 193(2):257-266.
63. Lukens J.N., Van Deerlin V., Clark C.M., Xie S.X., Johnson F.B. Comparisons of telomere lengths in peripheral blood and cerebellum in Alzheimer's disease. Alzheimers Dement. 2009, 5:463-469.
64. Magistretti P.J. Neuron-glia metabolic coupling and plasticity. J. Exp. Biol. 2006, 209:2304-2311.
65. Mai S., Klinkenberg M., Auburger G., Bereiter-Hahn J., Jendrach M. Decreased expression of Drp1 and Fis1 mediates mitochondrial elongation in senescent cells and enhances resistance to oxidative stress through PINK1. J. Cell Sci. 2010, 123:917-926.
66. Martin-Ruiz C., Dickinson H.O., Keys B., Rowan E., Kenny R.A., Von Zglinicki T. Telomere length predicts poststroke mortality, dementia, and cognitive decline. Ann. Neurol. 2006, 60(2):174-180.
67. Masutomi K., Yu E.Y., Khurts S., Ben-Porath I., Currier J.L., Metz G.B., Brooks M.W., Kaneko S., Murakami S., DeCaprio J.A., Weinberg R.A., Stewart S.A., Hahn W.C. Telomerase maintains telomere structure in normal human cells. Cell 2003, 114:241-253.
68. Mather K.A., Jorm A.F., Parslow R.A., Christensen H. Is telomere length a biomarker of aging? A review. J. Gerontol. A Biol. Sci. Med. Sci. 2011, 66(2):202-213.
69. Movérare-Skrtic S., Johansson P., Mattsson N., Hansson O., Wallin A., Johansson J.O., Zetterberg H., Blennow K., Svensson J. Leukocyte telomere length (LTL) is reduced in stable mild cognitive impairment but low LTL is not associated with conversion to Alzheimer's disease: a pilot study. Exp. Gerontol. 2012, 47(2):179-182.
70. Myung N.H., Zhu X., Kruman I.I., Castellani R.J., Petersen R.B., Siedlak S.L., Perry G., Smith M.A., Lee H.G. Evidence of DNA damage in Alzheimer disease: phosphorylation of histone H2AX in astrocytes. Age (Dordrecht) 2008, 30:209-215.
71. Nichols N.R., Day J.R., Laping N.J., Johnson S.A., Finch C.E. GFAP mRNA increases with age in rat and human brain. Neurobiol. Aging 1993, 14:421-429.
72. Ota Y., Zanetti A.T., Hallock R.M. The role of astrocytes in the regulation of synaptic plasticity and memory formation. Neural Plast. 2013, 2013:185463.
73. Panossian L.A., Porter V.R., Valenzuela H.F., Zhu X., Reback E., Masterman D., Cummings J.L., Effros R.B. Telomere shortening in T cells correlates with Alzheimer's disease status. Neurobiol. Aging 2003, 4:77-84.
74. Pelvig D.P., Pakkenberg H., Stark A.K., Pakkenberg B. Neocortical glial cell numbers in human brains. Neurobiol. Aging 2008, 29:1754-1762.
75. Rodríguez-Arellano J.J., Parpura V., Zorec R., Verkhratsky A. Astrocytes in physiological aging and Alzheimer's disease. Neuroscience 2015, S0306-4522(15):31-37.
76. Rolyan H., Scheffold A., Heinrich A., Begus-Nahrmann Y., Langkopf B.H., Hölter S.M., Vogt-Weisenhorn D.M., Liss B., Wurst W., Lie D.C., Thal D.R., Biber K., Rudolph K.L. Telomere shortening reduces Alzheimer's disease amyloid pathology in mice. Brain 2011, 134:2044-2056.
77. Rubio-Perez J.M., Morillas-Ruiz J.M. A Review: inflammatory process in Alzheimer's disease. Role of Cytokines ScientificWorld Journal 2012, 2012:756357.
78. Salminen A., Ojala J., Kaarniranta K., Haapasalo A., Hiltunen M., Soininen H. Astrocytes in the aging brain express characteristics of senescence-associated secretory phenotype. Eur. J. Neurosci. 2011, 34(1):3-11.
79. Sanders J.L., Newman A.B. Telomere length in epidemiology: a biomarker of aging, age-related disease, both, or neither?. Epidemiol. Rev. 2013, (Epub ahead of print).
80. Schneider L., Pellegatta S., Favaro R., Pisati F., Roncaglia P., Testa G., Nicolis S.K., Finocchiaro G., d'Adda di Fagagna F. DNA damage in mammalian neural stem cells leads to astrocytic differentiation mediated by BMP2 signaling through JAK-STAT. Stem Cell Rep. 2013, 1(2):123-138.
81. Selkoe D.J. Preventing Alzheimer's disease. Science 2012, 337:1488-1492.
82. Serrano-Pozo A., Frosh M.P., Masliah E., Hyman B.T. Neuropathological alterations in Alzheimer disease. Cold Spring Harbor Perspect. Med. 2011, 1:a006189.
83. Sfeir A.J., Chai W., Shay J.W., Wright W.E. Telomere end processing: the terminal nucleotides of human chromosomes. Mol. Cell 2005, 18:131-138.
84. Sokolova A., Hill M.D., Rahimi F., Warden L.A., Halliday G.M., Shepherd C.E. Monocyte chemoattractant protein-1 plays a dominant role in the chornic inflammation observed in Alzheimer's disease. Brain Pathol. 2008, 19:392-398.
85. Spilsbury A., Miwa S., Attems J., Saretzki G. The role of telomerase protein TERT in Alzheimer's disease and in tau-related pathology in vitro. J. Neurosci. 2015, 35(4):1659-1674.
86. Streit W.J., Xue Q.S., Tischer J., Bechmann I. Microglial pathology. Acta Neuropathol. Commun. 2014, 2(1):142.
87. Streit W.J. Microglia and the response to brain injury. Ernst Schering Res. Found. Workshop 2002, 39:11-24.
88. Streit W.J. Microglia as neuroprotective, immunocompetent cells of the CNS. Glia 2002, 40:133-139.
89. Tacutu R., Budovsky A., Yanai H., Fraifeld V.E. Molecular links between cellular senescence, longevity and agerelated diseases - a systems biology perspective. Aging 2011, 3:1178-1191.
90. Takata Y., Kikukawa M., Hanyu H., Koyama S., Shimizu S., Umahara T., Sakurai H., Iwamoto T., Ohyashiki K., Ohyashiki J.H. Association between ApoE phenotypes and telomere erosion in Alzheimer's disease. J. Gerontol. A Biol. Sci. Med. Sci. 2012, 67:330-335.
91. Tan F.C., Hutchison E.R., Eitan E., Mattson M.P. Are there roles for brain cell senescence in aging and neurodegenerative disorders?. Biogerontology 2014, 15(6):643-660.
92. Thomas P., O' Callaghan N.J., Fenech M. Telomere length in white blood cells, buccal cells and brain tissue and its variation with ageing and Alzheimer's disease. Mech. Ageing Dev. 2008, 129:183-190.
93. Tomás-Loba A., Flores I., Fernández-Marcos P.J., Cayuela M.L., Maraver A., Tejera A., Borrás C., Matheu A., Klatt P., Flores J.M., Viña J., Serrano M., Blasco M.A. Telomerase reverse transcriptase delays aging in cancer resistant mice. Cell 2008, 135:609-622.
94. Valdes A.M., Deary I.J., Gardner J., Kimura M., Lu X., Spector T.D., Aviv A., Cherkas L.F. Leukocyte telomere length is associated with cognitive performance in healthy women. Neurobiol. Aging 2010, 31:986-992.
95. Vera E., Bernardes de Jesus B., Foronda M., Flores J.M., Blasco M.A. The rate of increase of short telomeres predicts longevity in mammals. Cell Rep. 2012, 2(4):732-737.
96. Verkhratsky A. Impaired adult neurogenesis in the dentate gyrus of a triple transgenic mouse model of Alzheimer's disease. PloS One 2008, 3:e2935.
97. von Zglinicki T. Oxidative stress shortens telomeres. Trends Biochem. Sci. 2002, 27:339-344.
98. von Zglinicki T., Martin-Ruiz C.M. Telomeres as biomarkers for ageing and age-related diseases. Curr. Mol. Med. 2005, 5(2):197-203.
99. Wan C., Liu J., Nie X., Zhao J., Zhou S., Duan Z., Tang C., Liang L., Xu G. 2,3,7,8-Tetrachlorodibenzo-P-dioxin (TCDD) induces premature senescence in human and rodent neuronal cells via ROS-dependent mechanisms. PLoS One 2014, 9:e89811.
100. Wang J., Zhao C., Zhao A., Li M., Ren J., Qu X. New insights in amyloid beta interactions with human telomerase. J. Am. Chem. Soc. 2015, 137(3):1213-1219.
101. Weng N.P. Telomeres and immune competency. Curr. Opin. Immunol. 2012, 24:470-475.
102. Xie Z., Jay K.A., Smith D.L., Zhang Y., Liu Z., Zheng J., Tian R., Li H., Blackburn E.H. Early telomerase inactivation accelerates aging independently of telomere length. Cell 2015, 160(5):928-939.
103. Yu H.M., Zhao Y.M., Luo X.G., Feng Y., Ren Y., Shang H., He Z.Y., Luo X.M., Chen S.D., Wang X.Y. Repeated lipopolysaccharide stimulation induces cellular senescence in BV2 cells. Neuroimmunomodulation 2012, 19:131-136.
104. Zekry D., Herrmann F.R., Irminger-Finger I., Graf C., Genet C., Vitale A.M., Michel J.P., Gold G., Krause K.H. Telomere length and ApoE polymorphism in mild cognitive impairment, degenerative and vascular dementia. J. Neurol. Sci. 2010, 299:108-111.
105. Zekry D., Herrmann F.R., Irminger-Finger I., Ortolan L., Genet C., Vitale A.M., Michel J.P., Gold G., Krause K.H. Telomere length is not predictive of dementia or MCI conversion in the oldest old. Neurobiol. Aging 2010, 31:719-720.
106. Zhang J., Kong Q., Zhang Z., Ge P., Ba D., He W. Telomere dysfunction of lymphocytes in patients with Alzheimer disease. Cognit. Behav. Neurol. 2003, 16:170-176.
107. Zhu H., Fu W., Mattson M.P. The catalytic subunit of telomerase protects neurons against amyloid peptide-induced apoptosis. J. Neurochem. 2000, 75:117-124.
108. Zhu X., Rottkamp C.A., Raina A.K., Brewer G.J., Ghanbari H.A., Boux H., Smith M.A. Neuronal CDK7 in hippocampus is related to aging and Alzheimer disease. Neurobiol. Aging 2000, 21(6):807-813.
109. Zou Y., Zhang N., Ellerby L.M., Davalos A.R., Zeng X., Campisi J., Desprez P.Y. Responses of human embryonic stem cells and their differentiated progeny to ionizing radiation. Biochem. Biophys. Res. Commun. 2012, 426(1):100-105.